Talk:International Conference on Pharmacovigilance and Drug Development

Jump to: navigation, search

About this board

By clicking "Add topic", you agree to the terms of use for this wiki.

19th International Conference on Pharmacovigilance, Drug Development and Testing

1
1213 (Talkcontribs)
19th International Conference on Pharmacovigilance, Drug Development and Testing aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Pharmacovigilance, Drug Development and Testing. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Pharmacovigilance, Drug Development and Testing.

Call for Contributions All honorable authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Pharmacovigilance, Drug Development and Testing are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.WASET Conference Proceedings All submitted conference papers will be blind peer reviewed by three competent reviewers. The post conference proceedings will be abstracted and indexed in the International Science Index , and submitted to be indexed in the Google Scholar, Scopus and Thomson Reuters. The conference abstracts and proceedings book, CD and certificate of presentation will be distributed to participants at the conference registration desk. Special Journal Issues ICPDDT 2017 has teamed up with the Special Journal Issue on Pharmacovigilance, Drug Development and Testing. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge. Conference Sponsor and Exhibitor Opportunities The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form. Important Dates Abstracts/Full-Text Paper Submission Deadline July 14, 2017 Notification of Acceptance/Rejection July 30, 2017 Final Paper (Camera Ready) Submission & Early Bird Registration Deadline November 4, 2017 Conference Dates December 4 - 5, 2017e

There are no older topics